Evidence map›Paper›PMID 35171954›Full record

ArticlePloS one2022

Efficacy of a dietary supplement in dogs with osteoarthritis: A randomized placebo-controlled, double-blind clinical trial.

Elisa Martello, Mauro Bigliati, Raffaella Adami, Elena Biasibetti, Donal Bisanzio, Giorgia Meineri, Natascia Bruni

Open access · goldAbstract readRandomized Controlled Trial, Veterinary
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Elisa MartelloDivision of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham, United Kingdom.ORCID 0000-0003-0247-6670
Mauro BigliatiAmbulatorio Vernazza, Torino, Italy.
Raffaella AdamiCandioli Pharma S.r.l., Beinasco (TO), Italy.
Elena BiasibettiIstituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, Torino, Italy.
Donal BisanzioRTI International, Washington, DC, United States of America.
Giorgia MeineriDepartment of Veterinary Science, University of Turin, Grugliasco (TO), Italy.
Natascia BruniCandioli Pharma S.r.l., Beinasco (TO), Italy.
Gruppo di Ricerca Geriatrica · ITIstituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta · ITRTI International · USUniversity of Nottingham · GBUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study is a randomized, placebo-controlled, double-blinded trial performed to investigate the effects of a dietary supplement containing a mixture of Boswellia serrata Roxb., chlorophyll, green tea extract, glucosamine, chondroitin sulfate, hyaluronic acid, and further in the manuscript: non-hydrolised type II collagen in dogs with osteoarthritis (OA). A total of 40 dogs were enrolled in the study, they were randomly divided in control (CTR) and treatment (TRT) groups. The TRT group received the dietary supplement for 60 days. The CTR group received a placebo for the same number of days. All the subjects had veterinary evaluations during the trial and owners were requested to fill in questionnaires on chronic pain using the Helsinki Chronic Pain Index. The product was easy to administer and no side effects were reported. Combining results from veterinarian and owner evaluations, the tested product proved to be significantly beneficial in alleviating pain and in reducing the clinical signs in dogs with OA.

Indexed as

Dietary SupplementsAnimalsChondroitin SulfatesDogsDouble-Blind MethodGlucosamineHyaluronic AcidMaleOsteoarthritis, KneeTreatment OutcomeViscosupplementsChondroitin SulfatesGlucosamineHyaluronic AcidViscosupplements

Identifiers

PMID35171954
PMCPMC8849458
OpenAlexW4212780857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.